Derik De Bruin
Stock Analyst at B of A Securities
(4.53)
# 209
Out of 4,944 analysts
217
Total ratings
64.14%
Success rate
14.32%
Average return
Main Sectors:
Stocks Rated by Derik De Bruin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Buy | $116 → $110 | $90.93 | +20.97% | 3 | Jun 26, 2025 | |
| BRKR Bruker | Maintains: Buy | $61 → $50 | $34.54 | +44.76% | 13 | Jun 26, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $12 → $13 | $13.57 | -4.20% | 9 | Jun 26, 2025 | |
| QGEN Qiagen | Maintains: Buy | $50 → $53 | $49.23 | +7.66% | 6 | Jun 26, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,200 → $1,260 | $1,324.06 | -4.84% | 10 | Jun 26, 2025 | |
| WAT Waters | Maintains: Neutral | $370 → $375 | $296.83 | +26.33% | 14 | Jun 26, 2025 | |
| A Agilent Technologies | Maintains: Neutral | $156 → $128 | $120.29 | +6.41% | 33 | Apr 14, 2025 | |
| MYGN Myriad Genetics | Maintains: Underperform | $13 → $11 | $5.87 | +87.39% | 13 | Mar 3, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $72 → $65 | $44.91 | +44.73% | 7 | Feb 20, 2025 | |
| NEO NeoGenomics | Maintains: Neutral | $19 → $16 | $6.24 | +156.41% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $675 → $660 | $484.79 | +36.14% | 18 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $235 | $190.23 | +23.53% | 3 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $220 → $210 | $155.00 | +35.48% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $355 | $246.22 | +44.18% | 7 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $22.36 | +16.28% | 4 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $262 → $271 | $272.54 | -0.57% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $179 → $182 | $179.04 | +1.65% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $290 | $209.14 | +38.66% | 4 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $13 → $15 | $30.96 | -51.55% | 4 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $26 → $21 | $7.84 | +167.86% | 5 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $32 | $19.84 | +61.29% | 1 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $140 → $100 | $101.11 | -1.10% | 11 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $86 | $68.98 | +24.67% | 11 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $13 | $3.84 | +238.54% | 1 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $6.5 | $2.17 | +199.54% | 1 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $265 → $260 | $176.29 | +47.48% | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $240 → $120 | $13.26 | +804.98% | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $111 → $120 | $152.44 | -21.28% | 2 | Jul 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $10 → $9 | $2.33 | +286.27% | 7 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $235 | $663.92 | -64.60% | 3 | Nov 2, 2018 |
Revvity
Jun 26, 2025
Maintains: Buy
Price Target: $116 → $110
Current: $90.93
Upside: +20.97%
Bruker
Jun 26, 2025
Maintains: Buy
Price Target: $61 → $50
Current: $34.54
Upside: +44.76%
10x Genomics
Jun 26, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $13.57
Upside: -4.20%
Qiagen
Jun 26, 2025
Maintains: Buy
Price Target: $50 → $53
Current: $49.23
Upside: +7.66%
Mettler-Toledo International
Jun 26, 2025
Maintains: Neutral
Price Target: $1,200 → $1,260
Current: $1,324.06
Upside: -4.84%
Waters
Jun 26, 2025
Maintains: Neutral
Price Target: $370 → $375
Current: $296.83
Upside: +26.33%
Agilent Technologies
Apr 14, 2025
Maintains: Neutral
Price Target: $156 → $128
Current: $120.29
Upside: +6.41%
Myriad Genetics
Mar 3, 2025
Maintains: Underperform
Price Target: $13 → $11
Current: $5.87
Upside: +87.39%
Exact Sciences
Feb 20, 2025
Maintains: Buy
Price Target: $72 → $65
Current: $44.91
Upside: +44.73%
NeoGenomics
Feb 19, 2025
Maintains: Neutral
Price Target: $19 → $16
Current: $6.24
Upside: +156.41%
Dec 13, 2024
Maintains: Buy
Price Target: $675 → $660
Current: $484.79
Upside: +36.14%
Dec 13, 2024
Maintains: Buy
Price Target: $255 → $235
Current: $190.23
Upside: +23.53%
Dec 13, 2024
Maintains: Neutral
Price Target: $220 → $210
Current: $155.00
Upside: +35.48%
Dec 13, 2024
Maintains: Buy
Price Target: $350 → $355
Current: $246.22
Upside: +44.18%
Dec 13, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $22.36
Upside: +16.28%
Dec 13, 2024
Maintains: Buy
Price Target: $262 → $271
Current: $272.54
Upside: -0.57%
Dec 13, 2024
Maintains: Buy
Price Target: $179 → $182
Current: $179.04
Upside: +1.65%
Dec 13, 2024
Upgrades: Buy
Price Target: $290
Current: $209.14
Upside: +38.66%
Aug 30, 2024
Maintains: Underperform
Price Target: $13 → $15
Current: $30.96
Upside: -51.55%
Aug 13, 2024
Maintains: Underperform
Price Target: $26 → $21
Current: $7.84
Upside: +167.86%
Feb 29, 2024
Maintains: Neutral
Price Target: $38 → $32
Current: $19.84
Upside: +61.29%
Dec 12, 2023
Downgrades: Underperform
Price Target: $140 → $100
Current: $101.11
Upside: -1.10%
Aug 1, 2023
Maintains: Neutral
Price Target: $94 → $86
Current: $68.98
Upside: +24.67%
Jun 16, 2023
Downgrades: Neutral
Price Target: $13
Current: $3.84
Upside: +238.54%
Jan 4, 2023
Downgrades: Underperform
Price Target: $9 → $6.5
Current: $2.17
Upside: +199.54%
Nov 9, 2022
Upgrades: Buy
Price Target: $265 → $260
Current: $176.29
Upside: +47.48%
May 18, 2022
Downgrades: Underperform
Price Target: $240 → $120
Current: $13.26
Upside: +804.98%
Jul 1, 2019
Downgrades: Neutral
Price Target: $111 → $120
Current: $152.44
Upside: -21.28%
May 8, 2019
Reiterates: Underperform
Price Target: $10 → $9
Current: $2.33
Upside: +286.27%
Nov 2, 2018
Maintains: Buy
Price Target: $275 → $235
Current: $663.92
Upside: -64.60%